---
title: "JENKEM: Application for registration of sodium hyaluronate injection composite solution accepted"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/242158253.md"
description: "JENKEM announced that its wholly-owned subsidiary has submitted a registration application for sodium hyaluronate injection composite solution, which has been accepted by the National Medical Products Administration. This project is a Class III non-active implantable medical device aimed at improving adult skin dryness and dull complexion. The company will actively promote the approval process and disclose subsequent progress in a timely manner"
datetime: "2025-05-28T08:56:51.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/242158253.md)
  - [en](https://longbridge.com/en/news/242158253.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/242158253.md)
generator: "portal-rs"
---

# JENKEM: Application for registration of sodium hyaluronate injection composite solution accepted

JENKEM announced that its wholly-owned subsidiary Tianjin JENKEM Technology Co., Ltd. has submitted a registration application for the sodium hyaluronate injection composite solution independently developed by the company, which has been officially accepted by the Medical Device Technical Review Center of the National Medical Products Administration. The sodium hyaluronate injection composite solution project is a Class III passive implantable medical device independently developed by the company based on polyethylene glycol modification technology, intended for the indication of improving skin dryness and dull complexion in adults. The company will actively promote all work related to the approval of the above project and will fulfill its information disclosure obligations in a timely manner regarding the subsequent approval progress

### Related Stocks

- [688356.CN](https://longbridge.com/en/quote/688356.CN.md)

## Related News & Research

- [US health agencies report 55 cases of E. coli and salmonella infections tied to alfalfa sprouts](https://longbridge.com/en/news/296645342.md)
- [KINGSOFT  Interim Net Profit Up 100.8% YoY to RMB1.639 Billion; No Interim Dividend](https://longbridge.com/en/news/296417569.md)
- [CDC lifts beneficial stake in Exosens to 11.71% of capital, 13.87% of voting rights](https://longbridge.com/en/news/296499698.md)
- [US Treasury Secretary Bessent to hold press conference on Iran on Monday](https://longbridge.com/en/news/296511454.md)
- [JDC: Record growth in turnover and EBITDA, with strong outlook driven by new regulation and AI](https://longbridge.com/en/news/296247395.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**